Introduction
In summing up a series of papers Holland' suggested that screening might be more effectively aimed at identifying people with conditions such as disorders of vision that are amenable to alleviation rather than prevention or cure. Since 1967 a longterm study of multiphasic screening in middle age has been in progress in south London,2 and screening for impaired visual Department acuity was one component of the programme. The study therefore presented an opportunity to test Holland's hypothesis, as well as providing previously unavailable data on the prevalence of defective visual acuity in a middle-aged population.
Methods
The design and methodology of the south-east London screening study has been reported in detail elsewhere.3 Briefly, all people (n = 7229) aged 40-64 years who were registered in 1967 with two south London general practices were identified and randomly allocated into one of two groups, designated screening and control. The screening group (n = 3297) was invited by letter to attend an evening screening clinic at which a series of questions was asked and clinical tests carried out. Two years later this group was invited to a second, similar screening clinic. The control group (n = 3353) was not asked to either of these sessions. In 1972 both groups were invited to take part in a health survey so that direct comparisons of their clinical states could be made. The questions asked at the screening included: "Do you have difficulty in seeing distant objects (with spectacles if you have them) ?" and "Do you normally wear glasses for distant vision ?" The former question was self-administered and the latter asked by the interviewer.
Distant visual acuity was measured by using a standard Snellen card at six metres in moderate artificial lighting. Each eye was tested separately, with lens correction if available. The responses to the questions and the results of the tests were recorded, coded, punched on cards, and stored for analysis. The attention of the general practitioner was drawn to any abnormal result so that he might decide whether more definitive diagnosis or treatment (or both) was indicated.
Results
In this analysis impaired visual acuity was defined according to the criteria of the World Health Organisation-that is, as 6/18 or worse in the better eye, both eyes using best correction.4 The response rate at the initial screening was 7344%, rising to 8244% at the survey, for which more intensive efforts were made to contact non-responders. Response rates have previously been described in detail.5 Table I shows the prevalence (966%) of impaired visual acuity found at the initial screening in 1967. There was a trend towards poorer visual acuity with age. No difference was found between the sexes. Table II shows the presence of a social-class gradient, people in social class V having double the prevalence of impaired visual acuity of those in social class I. This effect was independent of age. The question "Do you have difficulty seeing distant objects (with spectacles if you have them) ?" was answered positively by 9-1% of the population. The ability of the question to identify people who when tested had impaired visual acuity was poor (sensitivity = 28-4%), though it successfully identified those with normal visual acuity (specificity = 92-9%; At the 1972 survey no significant differences were found in the prevalences of impaired visual acuity between the screening and control groups (table IV). The age gradient was still present, but no social-class trend was evident. Because the response rate was higher at the 1972 survey than at the initial screening in 1967 we were able to examine the prevalence of impaired visual acuity in those who refused screening but attended the survey. Table V shows that, although the numbers were small, the prevalences were similar to those in the screened population. The prevalence of spectacle wearing was examined at the survey. Overall, 47% of the population stated that they normally wore spectacles for distant vision. A pronounced increase in spectacle wearing with age was apparent (table VI). There were no significant differences in the prevalences of spectacle wearing in the screening and control groups by sex or age (table VII).
Discussion
Screening for visual disorders is usually concerned with the early detection of strabismus and amblyopia in children and glaucoma in adults. This paper describes one of the few attempts to detect and treat defects of distant visual acuity in middle-aged people. Visual impairment was present in 9-6% of the screened population by the WHO definition. Since attending a screening clinic may be a social task of considerable complexity for the most severely handicapped members of the community they were probably underrepresented in the screened population. The above figure may therefore underestimate the true prevalence. The sample is unknown, the results of this study raise questions about the effectiveness of current procedures in identifying the substantial proportion of middle-aged people whose visual acuity falls short of the legal requirement. After taking the driving test, which includes reading car numberplate letters at a fixed distance, a driver is obliged to notify the Vehicle Licensing Centre as soon as he becomes aware that his vision has deteriorated below the specified standard. On the evidence presented here, most middle-aged people with impaired distant visual acuity are unaware of their disability, a finding that casts doubt on the adequacy of existing legislation.
The slightly higher overall prevalence of visual impairment at the 1972 survey reflected the aging of the whole population over the five years. The lack of significant difference in the prevalence of impaired visual acuity between the screening and control groups suggests that screening had no measurable impact on distance vision. The explanation for this disappointing result probably lies in the multiphasic nature of the screening programme. A large volume of data was presented to each person's general practitioner, who was expected to assess the clinical importance of abnormal findings and, if necessary, arrange further investigation, treatment, and follow-up. Previously reported analyses have shown that the general practitioners initiated treatment for only a few of the abnormalities discovered at screening.2 In future studies of multiphasic screening it would be advisable either to reduce the scale of the examinations, concentrating on perhaps one or two systems, or to provide sufficient additional resources to exploit fully the yield of clinical information.
Finally, nearly half the study population claimed to wear spectacles for distant vision. This is five times the proportion found to have impaired distant vision on testing. Unless most of this lens correction is unnecessary spectacle wearing apparently limits the prevalence of impaired visual acuity in the community. More investigation is needed to establish whether improved quality or frequency of optical prescription would reduce it still further. Hopes that mass screening might fulfil such a role have not been realised. Summary and conclusions The pharmacokinetics of chlormethiazole were studied in eight patients with advanced cirrhosis of the liver and in six healthy volunteers after oral and intravenous administration of the drug. In the patients the systemic bioavailability of oral chlormethiazole was increased about tenfold, whereas its elimination was only slightly retarded. The increased bioavailability was clearly due to decreased first-pass metabolism of chlormethiazole in the cirrhotic liver.
The results indicate that chlormethiazole should be used in reduced dosage when given by mouth to patients with cirrhosis of the liver.
Introduction
Chlormethiazole is a derivative of the thiazole part of vitamin B,, and owing to its sedative-hypnotic and anticonvulsant properties it is widely used for treating restlessness and agitation -for example, in delirium tremens. Although chlormethiazole is thought to be relatively safe, several deaths have been described in association with its use, mostly after excessive dosage.'-4 Impaired liver function has been considered as a possible risk factor for chlormethiazole toxicity.3 Chlormethiazole is eliminated mainly by metabolism, only a very small amount being excreted unchanged in the urine. Furthermore, oral chlormethiazole undergoes extensive first-pass metabolism, which may be dose-dependent.5-7 In view of these properties of chlormethiazole changes could be expected to occur in its pharmacokinetics in patients with cirrhosis of the liver.
We have evaluated the absorption and elimination of chlormethiazole in patients with advanced cirrhosis of the liver and in a group of healthy volunteers.
Subjects and methods
Eight men with biopsy-proved alcoholic cirrhosis of the liver participated in the study. Laparoscopy with liver biopsy had been performed two to six months before. All had a history of alcohol abuse but abstained from alcohol for at least one month before the study. They had no other significant diseases. Six healthy male volunteers
